Gaithersburg’s Novavax Inc. (NASDAQ: NVAX) reported Tuesday positive phase 1 clinical trial data on its Covid-19 vaccine candidate, a necessary step to advance a product officials hope will eventually protect people from coronavirus. The study found the candidate, called NVX-CoV2373, to both be generally well-tolerated and elicit “robust antibody responses,” the company said Tuesday, adding that it showed the potential to reduce the disease’s transmission. Specifically, the candidate had…
from https://www.bizjournals.com/baltimore/news/2020/08/05/novavax-reports-positive-data-covid-vaccine.html?ana=RSS&s=article_search
via https://baltimorecheckbook.tumblr.com/post/625612474037796864
No comments:
Post a Comment